Nitric Oxide-Producing Cardiovascular Stent Coatings for Prevention of Thrombosis and Restenosis

Frontiers in Bioengineering and Biotechnology
Jingdong RaoXin Zhao

Abstract

Cardiovascular stenting is an effective method for treating cardiovascular diseases (CVDs), yet thrombosis and restenosis are the two major clinical complications that often lead to device failure. Nitric oxide (NO) has been proposed as a promising small molecule in improving the clinical performance of cardiovascular stents thanks to its anti-thrombosis and anti-restenosis ability, but its short half-life limits the full use of NO. To produce NO at lesion site with sufficient amount, NO-producing coatings (including NO-releasing and NO-generating coatings) are fashioned. Its releasing strategy is achieved by introducing exogenous NO storage materials like NO donors, while the generating strategy utilizes the in vivo substances such as S-nitrosothiols (RSNOs) to generate NO flux. NO-producing stents are particularly promising in future clinical use due to their ability to store NO resources or to generate large NO flux in a controlled and efficient manner. In this review, we first introduce NO-releasing and -generating coatings for prevention of thrombosis and restenosis. We then discuss the advantages and drawbacks on releasing and generating aspects, where possible further developments are suggested.

References

Mar 29, 2002·The New England Journal of Medicine·Gregg W StoneUNKNOWN Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators
Apr 26, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Mihail HristovPeter C Weber
Oct 18, 2003·American Heart Journal·Paul A Gurbel, Kevin P Bliden
May 26, 2004·Journal of Cell Science·William C Sessa
May 3, 2006·Advanced Drug Delivery Reviews·Hidehiko HaraRobert S Schwartz
Jul 4, 2006·Journal of the American College of Cardiology·Michael JonerRenu Virmani
Aug 30, 2008·The New England Journal of Medicine·Bruce Furie, Barbara C Furie
Dec 8, 2009·Biomaterials·Chye Khoon PohWilson Wang
May 5, 2010·Nitric Oxide : Biology and Chemistry·Andrea PautzHartmut Kleinert
Jun 15, 2011·Chemical Reviews·Achala de MelAlexander M Seifalian
Mar 1, 2012·Chemical Society Reviews·Alexis W Carpenter, Mark H Schoenfisch
Nov 9, 2012·Small·Noora NaghaviAlexander M Seifalian
Jan 16, 2013·Journal of Tissue Engineering and Regenerative Medicine·Stephen McIlhennyPaul DiMuzio
Jan 1, 2011·Cardiovascular Intervention and Therapeutics·Kenji OhkuboAkira Miyazaki
May 27, 2014·Frontiers in Endocrinology·Peishen ZhaoNigel W Bunnett
May 26, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhihong WangQiang Zhao
Jun 13, 2015·Journal of the American College of Cardiology·Tullio PalmeriniGregg W Stone
Aug 13, 2015·Nature Reviews. Drug Discovery·Jon O LundbergEddie Weitzberg
Feb 6, 2016·ACS Applied Materials & Interfaces·Grant C AlexanderHo-Wook Jun
Feb 14, 2016·Life Sciences·Eduardo Fuentes, Iván Palomo
Mar 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Iwona CichaChristoph Alexiou
Mar 26, 2016·JACC. Cardiovascular Interventions·Gregg W Stone
Feb 18, 2017·Circulation Research·Ulrich FörstermannHuige Li
Apr 1, 2017·Circulation Research·Jan R Kraehling, William C Sessa
Jun 6, 2017·Interventional Cardiology Clinics·Kenta NakamuraElazer Reuven Edelman
Jul 25, 2017·Advanced Drug Delivery Reviews·Settimio PacelliArghya Paul

❮ Previous
Next ❯

Citations

Oct 21, 2020·Biomaterials Science·Jingdong RaoXin Zhao

❮ Previous
Next ❯

Methods Mentioned

BETA
transfect
transfection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.